Jose R. Gutierrez Md Pc - Medicare Primary Care in Acton, MA

Jose R. Gutierrez Md Pc is a medicare enrolled primary clinic (Internal Medicine - Geriatric Medicine) in Acton, Massachusetts. The current practice location for Jose R. Gutierrez Md Pc is 1 Great Rd, Acton, Massachusetts. For appointments, you can reach them via phone at (978) 263-9101. The mailing address for Jose R. Gutierrez Md Pc is 10 Eagles Nest Rd, Westford, Massachusetts and phone number is (646) 537-5170.

Jose R. Gutierrez Md Pc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1851987663. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (978) 263-9101.

Contact Information

Jose R. Gutierrez Md Pc
1 Great Rd
Acton
MA 01720-5601
(978) 263-9101
Not Available

Primary Care Clinic Profile

Full NameJose R. Gutierrez Md Pc
SpecialityInternal Medicine
Location1 Great Rd, Acton, Massachusetts
Authorized Official Name and PositionJose R. Gutierrez (PRESIDENT)
Authorized Official Contact6465375170
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jose R. Gutierrez Md Pc
10 Eagles Nest Rd
Westford
MA 01886-1396

Ph: (646) 537-5170
Jose R. Gutierrez Md Pc
1 Great Rd
Acton
MA 01720-5601

Ph: (978) 263-9101

NPI Details:

NPI Number1851987663
Provider Enumeration Date12/15/2020
Last Update Date12/15/2020

Medicare PECOS Information:

Medicare PECOS PAC ID9830507763
Medicare Enrollment IDO20210414001433

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Jose R. Gutierrez Md Pc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1851987663NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RG0300XInternal Medicine - Geriatric Medicine (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Jose R. Gutierrez Md Pc acts as a billing entity for following providers:
Provider NameNoah Finkel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1831133008
PECOS PAC ID: 4183625296
Enrollment ID: I20070116000232

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

Provider NameJose Ramon Gutierrez
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1437377967
PECOS PAC ID: 3971699968
Enrollment ID: I20071023000074

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

Provider NameEliesel G Lacerda De La Cruz
Provider TypePractitioner - Infectious Disease
Provider IdentifiersNPI Number: 1831363779
PECOS PAC ID: 3375603764
Enrollment ID: I20081114000396

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

Provider NameSandra Buss
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1629122700
PECOS PAC ID: 9638207368
Enrollment ID: I20100517000483

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

Provider NameMuhammad S Mowla
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1720286289
PECOS PAC ID: 8628109683
Enrollment ID: I20100708000594

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

Provider NameRafael Bloise Espinal
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1689933392
PECOS PAC ID: 0345490074
Enrollment ID: I20121015000638

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

Provider NameCaroline Namuzinda Mawanda
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1154821114
PECOS PAC ID: 4082979000
Enrollment ID: I20180522002709

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

Provider NameHannah Flynn
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1851896427
PECOS PAC ID: 8820343098
Enrollment ID: I20180613000289

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

Provider NameEnid S Landreth
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1811569825
PECOS PAC ID: 6800254582
Enrollment ID: I20230628002046

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

Provider NameAnne Kananura
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1144892571
PECOS PAC ID: 1951762137
Enrollment ID: I20230803003566

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more Medical News

› Verified 9 days ago

News Archive

Repurposed drug effectively protects against Zika virus in mouse models

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

BDV installs IDSS video and audio solutions in Saint Francis', John T. O'Connell Tower

Black Diamond Video, Inc. has completed installation of its state-of-the-art Integrated Digital Surgical Suite video and audio solutions in Saint Francis Hospital and Medical Center's new John T. O'Connell Tower.

Read more News

› Verified 9 days ago


Internal Medicine in Acton, MA

Kronos Health Pllc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 57 Mohawk Dr, Acton, MA 01720
Phone: 978-290-1009    Fax: 978-475-8886
Barron Chiropractic & Wellness Center Inc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 83 Great Rd Ste 1a, Acton, MA 01720
Phone: 978-266-9286    Fax: 978-266-9296
Integrative Family Medicine Associates
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 529 Main St Ste B, Acton, MA 01720
Phone: 978-635-1800    
Acton Medical Associates, Pc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 321 Main St, Acton, MA 01720
Phone: 978-635-8801    Fax: 978-635-8920
Medi-check Medical Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 436 Great Road, Acton, MA 01720
Phone: 978-263-3332    Fax: 978-263-2386

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.